Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
22.86
-0.76 (-3.22%)
At close: May 8, 2026, 4:00 PM EDT
22.95
+0.09 (0.39%)
After-hours: May 8, 2026, 6:44 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $316.71 million as of May 8, 2026. Its market cap has increased by 142.24% in one year.
Market Cap
316.71M
Enterprise Value
323.51M
1-Year Change
142.24%
Ranking
Category
Stock Price
$22.86
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $316.71M, an increase of 361.09%. That is a compound annual growth rate of 31.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 327.24M | 12.42% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 331.63M |
| Palisade Bio | 329.83M |
| Inhibikase Therapeutics | 328.97M |
| Anavex Life Sciences | 311.38M |
| NervGen Pharma | 305.11M |
| AC Immune | 298.60M |
| Editas Medicine | 297.53M |
| Protara Therapeutics | 292.60M |